{
    "title": "Bristol Myers profit beats estimates on resilient Revlimid sales",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11053883/Bristol-Myers-profit-beats-estimates-resilient-Revlimid-sales.html",
    "date": "2022-07-27",
    "keywords": [
        "profit",
        "quarter",
        "share",
        "cancer",
        "drug",
        "revlimid",
        "market",
        "analyst",
        "bristol",
        "year",
        "company",
        "july",
        "co",
        "wednesday",
        "secondquarter",
        "blockbuster",
        "steeply",
        "competition",
        "drugmaker",
        "impact",
        "dollar",
        "opening",
        "bell",
        "beat",
        "exclusivity",
        "launch",
        "revenue",
        "chief",
        "david",
        "interview",
        "blood",
        "thinner",
        "pfizer",
        "immunotherapy",
        "opdivo",
        "line",
        "reporting",
        "erman",
        "jersey",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "bill",
        "berkrot",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}